Table S2.
Multivariate Cox proportional hazards regression analysis by region for OS in RCC and mRCC patients in Norway diagnosed between 2002 and 2011
| Regions | RCC (n=5,463)
|
mRCC (n=1,678)
|
||
|---|---|---|---|---|
| HR (95% CI)a | P-value | HR (95% CI)a | P-value | |
| Østfold | 1.000 | – | 1.000 | – |
| Akershus | 0.786 (0.644–0.958) | 0.017 | 0.924 (0.709–1.206) | 0.563 |
| Hedmark | 0.964 (0.762–1.219) | 0.757 | 1.156 (0.850–1.574) | 0.356 |
| Oppland | 0.715 (0.555–0.922) | 0.010 | 1.077 (0.777–1.493) | 0.657 |
| Buskerud | 0.964 (0.768–1.210) | 0.751 | 1.205 (0.885–1.642) | 0.236 |
| Vestfold | 0.858 (0.679–1.083) | 0.198 | 0.969 (0.720–1.306) | 0.838 |
| Telemark | 0.972 (0.762–1.241) | 0.820 | 0.993 (0.716–1.377) | 0.967 |
| Aust-Agder | 1.088 (0.768–1.540) | 0.635 | 1.447 (0.952–2.199) | 0.084 |
| Vest-Agder | 0.721 (0.547–0.950) | 0.020 | 0.962 (0.665–1.393) | 0.838 |
| Rogaland | 0.925 (0.753–1.135) | 0.453 | 1.188 (0.897–1.573) | 0.230 |
| Hordaland | 0.718 (0.583–0.885) | 0.002 | 0.945 (0.717–1.246) | 0.690 |
| Sogn og fjordane | 0.943 (0.694–1.282) | 0.709 | 1.110 (0.734–1.679) | 0.620 |
| Møre og Romsdal | 0.628 (0.496–0.795) | <0.001 | 0.966 (0.710–1.313) | 0.824 |
| Sør-Trøndelag | 0.632 (0.503–0.795) | <0.001 | 0.820 (0.598–1.123) | 0.216 |
| Nord-Trøndelag | 0.653 (0.486–0.876) | 0.004 | 1.145 (0.792–1.654) | 0.471 |
| Nordland | 1.030 (0.833–1.274) | 0.784 | 1.024 (0.775–1.354) | 0.865 |
| Troms | 0.909 (0.689–1.199) | 0.499 | 0.910 (0.629–1.316) | 0.616 |
| Finnmark | 0.874 (0.627–1.217) | 0.425 | 1.209 (0.786–1.858) | 0.388 |
| Oslo | 0.892 (0.731–1.088) | 0.261 | 1.078 (0.823–1.413) | 0.585 |
Note:
a
Regional estimates of HR that were adjusted for in the analysis for the mRCC model.
Abbreviations: CI, confidence interval; HR, hazard ratio; mRCC, metastatic renal cell carcinoma; OS, overall survival; RCC, renal cell carcinoma.